Cognitive Function and Neuropsychological Comorbidities in Children with Newly Diagnosed Idiopathic Epilepsy

Seung Yun Lee1, Jang Ho Park2, Sin Jae Park2

  • 1Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

Insights

Newly diagnosed idiopathic epilepsy in children is linked to cognitive issues and comorbidities like ADHD, depression, and anxiety. Bilateral epileptiform discharges on EEG correlate with lower cognitive function in these patients.

Area of Science:

  • Pediatric Neurology
  • Neuropsychology
  • Epileptology

Background:

  • Idiopathic epilepsy is a common neurological disorder in children.
  • Cognitive function and neuropsychological comorbidities can significantly impact a child's development and quality of life.
  • Early identification of these issues is crucial for effective management.

Purpose of the Study:

  • To identify cognitive function and neuropsychological comorbidities in children with newly diagnosed idiopathic epilepsy.
  • To investigate the association between cognitive performance and epilepsy classification, EEG findings, and seizure variables.

Main Methods:

  • Retrospective review of 97 antiepileptic drug-naïve children with newly diagnosed idiopathic epilepsy.
  • Administration of a comprehensive neuropsychological battery, including intelligence scales, ADHD, depression, and anxiety inventories.
  • Analysis of associations between neuropsychological scores and epilepsy classification, interictal epileptiform discharges (IEDs) lateralization, and seizure characteristics.

Main Results:

  • 14.3% of patients exhibited ADHD symptoms, 4.1% depressive symptoms, and 12.3% anxiety symptoms.
  • Patients with idiopathic generalized epilepsy (IGE) showed lower full-scale and performance IQ scores compared to those with idiopathic localization-related epilepsy (ILRE).
  • ILRE patients with unilateral IEDs had higher IQ scores than those with bilateral IEDs and IGE patients.

Conclusions:

  • Idiopathic epilepsy in children is frequently associated with neuropsychological comorbidities at diagnosis.
  • Children with IGE and ILRE with bilateral IEDs on EEG are at higher risk for reduced cognitive function.
  • These findings underscore the importance of comprehensive neuropsychological assessment in newly diagnosed pediatric epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
711
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K